The use of heterologous promoters for adeno-associated virus (AAV) protein expression in AAV vector production

被引:15
|
作者
Ogasawara, Y
Urabe, M
Ozawa, K
机构
[1] Jichi Med Sch, Inst Hematol, Dept Mol Biol, Minami Kawachi, Tochigi 3290431, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med 2, Tokyo 1050003, Japan
关键词
AAV vector; helper plasmid; heterologous promoter; gene therapy;
D O I
10.1111/j.1348-0421.1998.tb02269.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although adeno-associated virus (AAV) vectors are potentially useful gene transfer vehicles for gene therapy, the vector production system is currently at the developmental stage. We constructed AAV helper plasmids (Rep and Cap expression plasmids) by replacing a native AAV promoter, p5, with various heterologous promoters to examine whether the efficiency of AAV vector production was influenced by modulating the AAV protein expression pattern. The helper plasmids containing heterologous promoters (EF, CMV, SV40, B19p6, and CAG promoters, respectively) expressed Rep78/68 more efficiently than a conventional helper plasmid (pIM45), but the expression of Rep52/40 and Cap decreased, resulting in a significant reduction in AAV vector production. Furthermore, the efficiency of vector production never fully recovered even if the Cap proteins were supplied by an additional expression plasmid. A large amount of Rep78/68 and/or a reduced level of Rep52/40 may have deleterious effects on AAV vector production. The present findings will aid in the development of a more efficient AAV vector production system.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 50 条
  • [41] Adeno-associated virus (AAV) vectors in cancer gene therapy
    Santiago-Ortiz, Jorge L.
    Schaffer, David V.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2016, 240 : 287 - 301
  • [42] ROLE OF ADENO-ASSOCIATED VIRUS (AAV) IN INTERFERON INDUCTION BY ADENOVIRUSES
    BAKAY, M
    TOTH, M
    NAGY, E
    [J]. ACTA MICROBIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1975, 22 (03): : 347 - 347
  • [43] Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor
    Pillay, Sirika
    Zou, Wei
    Cheng, Fang
    Puschnik, Andreas S.
    Meyer, Nancy L.
    Ganaie, Safder S.
    Deng, Xuefeng
    Wosen, Jonathan E.
    Davulcu, Omar
    Yan, Ziying
    Engelhardt, John F.
    Brown, Kevin E.
    Chapman, Michael S.
    Qiu, Jianming
    Carette, Jan E.
    [J]. JOURNAL OF VIROLOGY, 2017, 91 (18)
  • [44] Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
    Nieuwenhuis, Bart
    Laperrousaz, Elise
    Tribble, James R.
    Verhaagen, Joost
    Fawcett, James W.
    Martin, Keith R.
    Williams, Pete A.
    Osborne, Andrew
    [J]. GENE THERAPY, 2023, 30 (06) : 503 - 519
  • [45] Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters
    Bart Nieuwenhuis
    Elise Laperrousaz
    James R. Tribble
    Joost Verhaagen
    James W. Fawcett
    Keith R. Martin
    Pete A. Williams
    Andrew Osborne
    [J]. Gene Therapy, 2023, 30 : 503 - 519
  • [46] Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) Vector
    Barnard, Alun R.
    Groppe, Markus
    MacLaren, Robert E.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (03):
  • [47] Role of the membrane-associated accessory protein (MAAP) in adeno-associated virus (AAV) infection
    Kuz, Cagla Aksu
    Ning, Kang
    Hao, Siyuan
    Cheng, Fang
    Qiu, Jianming
    [J]. JOURNAL OF VIROLOGY, 2024, 98 (06)
  • [48] Effect of prophylactic corticosteroid treatment on adeno-associated virus (AAV)-mediated gene expression
    Handyside, B.
    Zhang, L.
    Yates, B.
    Xie, L.
    Sihn, C. R.
    Liu, S.
    Bouwman, T.
    Kaplowitz, B.
    Razon, L.
    Gorostiza, O.
    Murphy, R.
    Fredette, N.
    Baridon, B.
    Ngo, K.
    Siso, S.
    Agrawal, V.
    Cortesio, C.
    Akeefe, H.
    Woloszynek, J.
    Zhang, W.
    Su, C.
    Colosi, P.
    Bullens, S.
    Veres, G.
    Bunting, S.
    Fong, S.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A131
  • [49] Improved Splicing of Adeno-Associated Viral (AAV) Capsid Protein-Supplying Pre-mRNAs Leads to Increased Recombinant AAV Vector Production
    Farris, K. David
    Pintel, David J.
    [J]. HUMAN GENE THERAPY, 2008, 19 (12) : 1421 - 1427
  • [50] The Effect of Prophylactic Corticosteroid Treatment on Adeno-Associated Virus (AAV)-Mediated Gene Expression
    Handyside, Britta
    Zhang, Lening
    Yates, Bridget
    Xie, Lin
    Kaplowitz, Brian
    Gorostiza, Olivia
    Murphy, Ryan
    Fredette, Natalie
    Baridon, Brian
    Ngo, Katina
    Siso, Silvia
    Agrawal, Vishal
    Cortesio, Christa
    Akeefe, Hassib
    Woloszynek, Jill
    Zhang, Weiming
    Su, Cheng
    Colosi, Peter
    Bullens, Sherry
    Veres, Gabor
    Bunting, Stuart
    Fong, Sylvia
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 167 - 167